Autonomic Pharmacology

Organophosphate Toxicity Practice Questions

20 free Organophosphate Toxicity practice questions for the Pharmacology, each with the correct answer and a detailed explanation. Open any question below, or take the full set as an interactive quiz.

Start Practice Quiz

Questions

All Organophosphate Toxicity questions

20 questions
  1. Q1. Organophosphate toxicity primarily results from inhibition of which enzyme?
  2. Q2. Which of the following is a classic muscarinic manifestation of organophosphate poisoning?
  3. Q3. Which antidote competitively blocks muscarinic receptors in organophosphate poisoning?
  4. Q4. Pralidoxime is effective in organophosphate poisoning because it:
  5. Q5. Which symptom represents a nicotinic effect of organophosphate toxicity?
  6. Q6. Which mnemonic describes muscarinic symptoms of organophosphate poisoning?
  7. Q7. Which of the following is a central nervous system manifestation of severe organophosphate toxicity?
  8. Q8. What is the primary cause of death in severe organophosphate poisoning?
  9. Q9. Which laboratory finding supports the diagnosis of organophosphate poisoning?
  10. Q10. Aging in organophosphate poisoning refers to:
  11. Q11. Which route of exposure is common in agricultural organophosphate poisoning?
  12. Q12. Which sign distinguishes organophosphate poisoning from anticholinergic toxicity?
  13. Q13. Which immediate management step is essential in suspected organophosphate exposure?
  14. Q14. Which autonomic division is overstimulated in organophosphate poisoning?
  15. Q15. Which of the following is NOT a typical feature of organophosphate poisoning?
  16. Q16. Which symptom indicates nicotinic receptor overstimulation at autonomic ganglia?
  17. Q17. Which of the following drugs can cross the blood-brain barrier to treat central effects?
  18. Q18. Delayed neuropathy following organophosphate exposure is due to:
  19. Q19. Which patient group is at higher risk for severe organophosphate toxicity?
  20. Q20. The primary pharmacologic goal in treating organophosphate toxicity is to: